Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher C Striebich

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Arthritis and Rheumatism|December 21, 2011
Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity?M Kristen Demoruelle, Michael H Weisman, Philip L Simonian, et al.
Rheumatology (Oxford, England)|October 20, 2019
A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritisCynthia Aranow, John Cush, Marcy B Bolster, et al.
Annals of the Rheumatic Diseases|November 8, 2015
Increased pretreatment serum IFN-β/α ratio predicts non-response to tumour necrosis factor α inhibition in rheumatoid arthritisTheresa Wampler Muskardin, Priyanka Vashisht, Jessica M Dorschner, et al.
Medrxiv : the Preprint Server for Health Sciences|February 27, 2026
Longitudinal peripheral blood multi-omic profiling in seropositive individuals identifies immune endotypes and predictive models for future rheumatoid arthritis conversionJun Inamo, Aleksandra Bylinska, Miles Smith, et al.
Nature Communications|November 22, 2023
Multifaceted immune dysregulation characterizes individuals at-risk for rheumatoid arthritisEddie A James, V Michael Holers, Radhika Iyer, et al.
Plos One|January 14, 2021
Diminished cytokine-induced Jak/STAT signaling is associated with rheumatoid arthritis and disease activityJason Ptacek, Rachael E Hawtin, Dongmei Sun, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 30, 2025
A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritisKevin D Deane, Christopher C Striebich, Marie L Feser, et al.
Science Translational Medicine|September 24, 2025
Progression to rheumatoid arthritis in at-risk individuals is defined by systemic inflammation and by T and B cell dysregulationZiyuan He, Marla C Glass, Pravina Venkatesan, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Systemic inflammation and lymphocyte activation precede rheumatoid arthritisZiyuan He, Marla C Glass, Pravina Venkatesan, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Arthritis and Rheumatism|December 21, 2011
Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity?M Kristen Demoruelle, Michael H Weisman, Philip L Simonian, et al.
Rheumatology (Oxford, England)|October 20, 2019
A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritisCynthia Aranow, John Cush, Marcy B Bolster, et al.
Annals of the Rheumatic Diseases|November 8, 2015
Increased pretreatment serum IFN-β/α ratio predicts non-response to tumour necrosis factor α inhibition in rheumatoid arthritisTheresa Wampler Muskardin, Priyanka Vashisht, Jessica M Dorschner, et al.
Medrxiv : the Preprint Server for Health Sciences|February 27, 2026
Longitudinal peripheral blood multi-omic profiling in seropositive individuals identifies immune endotypes and predictive models for future rheumatoid arthritis conversionJun Inamo, Aleksandra Bylinska, Miles Smith, et al.
Nature Communications|November 22, 2023
Multifaceted immune dysregulation characterizes individuals at-risk for rheumatoid arthritisEddie A James, V Michael Holers, Radhika Iyer, et al.
Plos One|January 14, 2021
Diminished cytokine-induced Jak/STAT signaling is associated with rheumatoid arthritis and disease activityJason Ptacek, Rachael E Hawtin, Dongmei Sun, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 30, 2025
A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritisKevin D Deane, Christopher C Striebich, Marie L Feser, et al.
Science Translational Medicine|September 24, 2025
Progression to rheumatoid arthritis in at-risk individuals is defined by systemic inflammation and by T and B cell dysregulationZiyuan He, Marla C Glass, Pravina Venkatesan, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Systemic inflammation and lymphocyte activation precede rheumatoid arthritisZiyuan He, Marla C Glass, Pravina Venkatesan, et al.
Pageof 2